Financials
Financial year 2025
Apexor from Gent, company number BE1011188574, closed financial year 2025 with a result of € 50,043 after tax. For that financial year Apexor recorded a gross margin of € 64,689 and equity of € 63,548. Compared with financial year 2024, the result moved from € 15,072 to € 50,043. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 63,548
▲ € 49,210 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 50,043
▲ 232% vs 2024
Profit after tax over the fiscal year.
€ 79,201
▲ € 63,784 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 833 paid out
2 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,283
▼ 20% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 27,929
▲ 176% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 19,561 | € 64,689 | ▲ 231% |
| Profit after taxes | € 15,072 | € 50,043 | ▲ 232% |
| Equity | € 14,339 | € 63,548 | ▲ € 49,210 |
| Total debts | € 14,095 | € 29,698 | ▲ 111% |
| Cash | € 15,418 | € 79,201 | ▲ € 63,784 |
| Retained profit | € 14,239 | € 63,448 | ▲ € 49,210 |
| Dividend | € 833 | € 833 | |
| Balance sheet total | € 28,434 | € 93,247 | ▲ 228% |
Key figures of Apexor, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apexor?
What happened at Apexor in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 50,043 (▲ 232% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 15,072 profit in 2024 to € 50,043 profit in 2025.
Paid € 17,841 in corporate taxes since 2024.
Best year ever: 2025, with € 50,043 profit.
Paid out € 1,666 in dividends to the owners in total.
Management
Behind Apexor is ROBBE CHAMPAGNE. ROBBE CHAMPAGNE is also behind Mise en Place BE.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Ooilamstraat 23
9000 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1011.188.574
- VAT number
- BE 1011.188.574
- Registered office
- Ooilamstraat 23, 9000 Gent
- Names & denominations
- Apexor
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 July 2024
- Peppol
- Active · Active since 2 Jan 2025
- Activities · NACE
Activiteiten van holdings
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Activiteiten van hoofdkantoren
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering